CanScan Community Registry for Cancer Prevention and Screening Tracking Cancer Risk and Early Detection in Adults

What this Trial Is About

Early diagnosis of cancer improves treatment outcomes, survival rates, and reduces care costs. Monitoring cancer in people at risk is crucial for early detection. The HMH Hennessey Institute for Cancer prevention and Applied Molecular Science HICAP offers clinical cancer screening and risk assessment, along with research on cancer risk and prevention. This study, the CanScan registry, will collect data over time from participants through questionnaires and routine assessments to better understand cancer risk, screening, and diagnostics. Participants will provide data via questionnaires and consent to share information from standard non-research assessments. The registry will gather information on genetic, environmental, and lifestyle factors linked to cancer risk. This observational study does not involve experimental treatments but follows participants to observe cancer-related outcomes and risk factors over time. Participants will be followed for up to 10 years, during which researchers will monitor rates of inherited genetic variants linked to cancer, new cancer cases, genetic risk scores, lifestyle influences, and the impact of early detection on cancer outcomes. Involvement includes completing questionnaires and allowing access to routine clinical data. This long-term observation aims to improve understanding and prevention of cancer in at-risk populations.

CanScan; Community-based Registry to Assess, Address and advaNce SCreening for cANcer Prevention and Management